More articles from 5.1 Airway Pharmacology and Treatment

A single-dose double-blind study comparing efficacy of two dry powder inhalers containing budesonide and formoterol in asthmatic patients
Satu Lahelma, Mikko Vahteristo, Hristo Metev, Margarita Taseva, Nadezhda Stamatova, Anna Bartha, Judit Schlezák, Ulla Sairanen

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4124; DOI: 10.1183/13993003.congress-2016.PA4124
Fluticasone propionate/formoterol breath-triggered inhaler: Ease-of-use and patient preference
David Bell, Lucielle Mansfield, Mark Lomax

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4109; DOI: 10.1183/13993003.congress-2016.PA4109
Secondary analysis of the UPLIFT® trial by body mass index
Donald P. Tashkin, Antonio Anzueto, Norbert Metzdorf, Achim Mueller, Ulrika Hinkel, Bartolome Celli

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4049; DOI: 10.1183/13993003.congress-2016.PA4049
Treatment of combined pulmonary fibrosis and emphysema
Jee Youn Oh, Juwhan Choi, Sangmi Chung, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Kyung Ho Kang

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4081; DOI: 10.1183/13993003.congress-2016.PA4081
MUC1-CT mediates corticosteroid responses in COPD
Lucia Diaz, Javier Milara, Esteban Morcillo, Adela Serrano, Ricardo Guijarro, Celia Sanz, Julio Cortijo

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4095; DOI: 10.1183/13993003.congress-2016.PA4095
Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients
Mathieu Molimard, C. Raherison, S. Lamarque, S. Lignot-Maleyran, A. Balestra, A. Chartier, R. Lassalle, C. Droz-Perroteau, P.O. Girodet

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4078; DOI: 10.1183/13993003.congress-2016.PA4078
Onset of action of formoterol/budesonide (F/B) Spiromax® compared with F/B Turbuhaler® in patients with COPD: A preliminary report
Josuel Ora, Alessandra Di Paolo, Gabriella Lucà, Luigino Calzetta, Paola Rogliani, Mario Cazzola

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4059; DOI: 10.1183/13993003.congress-2016.PA4059
Experience of application the selective phosphodiesterase-4 inhibitor roflumilast in the patient with COPD and the metabolic syndrome
Elena Blinova, Galina Ignatova, Maria Belsner

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4068; DOI: 10.1183/13993003.congress-2016.PA4068
Glaucoma risk due to antimuscarinics, not a class effect: A systematic review
Carlos Andrés Celis Preciado, Horacio Giraldo, Dario Londoño, Ingrid Rodriguez

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4069; DOI: 10.1183/13993003.congress-2016.PA4069
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Olaf Schmidt, Frank Kanniess, Petra Oepen, Birgit Langer-Brauburger

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4118; DOI: 10.1183/13993003.congress-2016.PA4118

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages

Contact us